MedCap Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MedCap.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Life Sciences earnings growth	45.1%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MedCap has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OM:MCAP - Analysts future estimates and past financials data (SEK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	1,600	172	189	228	N/A
9/30/2023	1,466	150	77	114	N/A
6/30/2023	1,343	149	61	97	N/A
3/31/2023	1,241	123	47	82	N/A
12/31/2022	1,124	118	41	86	N/A
9/30/2022	1,056	118	100	167	N/A
6/30/2022	1,017	107	78	146	N/A
3/31/2022	967	102	85	156	N/A
12/31/2021	926	97	55	116	N/A
9/30/2021	896	76	77	109	N/A
6/30/2021	869	64	60	90	N/A
3/31/2021	845	67	79	104	N/A
12/31/2020	828	63	91	115	N/A
9/30/2020	802	55	64	88	N/A
6/30/2020	786	53	75	101	N/A
3/31/2020	763	47	38	62	N/A
12/31/2019	757	55	41	71	N/A
9/30/2019	734	43	80	87	N/A
6/30/2019	740	41	70	107	N/A
3/31/2019	727	32	64	103	N/A
12/31/2018	709	24	56	91	N/A
9/30/2018	716	14	19	57	N/A
6/30/2018	689	8	13	27	N/A
3/31/2018	660	10	31	46	N/A
12/31/2017	617	7	14	41	N/A
10/31/2017	779	11	N/A	79	N/A
7/31/2017	802	3	N/A	85	N/A
4/30/2017	853	0	N/A	81	N/A
1/31/2017	901	5	N/A	32	N/A
10/31/2016	897	10	N/A	-18	N/A
7/31/2016	874	19	N/A	-44	N/A
4/30/2016	818	20	N/A	-15	N/A
1/31/2016	817	18	N/A	-60	N/A
10/31/2015	818	17	N/A	-28	N/A
7/31/2015	825	8	N/A	14	N/A
4/30/2015	855	9	N/A	2	N/A
1/31/2015	891	9	N/A	50	N/A
10/31/2014	913	15	N/A	26	N/A
7/31/2014	910	21	N/A	-1	N/A
4/30/2014	827	23	N/A	1	N/A
1/31/2014	651	18	N/A	29	N/A
10/31/2013	517	11	N/A	47	N/A
7/31/2013	402	17	N/A	57	N/A
4/30/2013	349	15	N/A	39	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MCAP's forecast earnings growth is above the savings rate (0.9%).

Earnings vs Market: Insufficient data to determine if MCAP's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if MCAP's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MCAP's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if MCAP's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MCAP's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

MedCap Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)

New 90-day low: kr193

MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

An unknown buyer acquired 10.1% stake in MedCap AB (publ) (OM:MCAP) from Bure Equity AB (publ) (OM:BURE).

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Market bids up stock over the past week

New 90-day high: kr233

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Revenue and earnings miss expectations

Third quarter 2020 earnings released: EPS kr0.89

New 90-day high: kr227

New 90-day high - kr207

MedCap AB (publ) to Report Q2, 2021 Results on Jul 30, 2021

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies